Lifeward (NASDAQ:LFWD) Trading Down 2.1% – What’s Next?

Lifeward Ltd. (NASDAQ:LFWD)’s share price traded down 2.1% during mid-day trading on Thursday . The company traded as low as $0.5150 and last traded at $0.52. 139,117 shares traded hands during trading, a decline of 37% from the average session volume of 219,376 shares. The stock had previously closed at $0.5311.

Wall Street Analysts Forecast Growth

LFWD has been the topic of several research reports. Weiss Ratings reissued a “sell (e+)” rating on shares of Lifeward in a research note on Thursday, January 22nd. HC Wainwright cut their price objective on shares of Lifeward from $13.00 to $4.50 and set a “buy” rating for the company in a report on Tuesday, November 18th. Two investment analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $4.25.

Lifeward Stock Performance

The stock has a market cap of $9.51 million, a PE ratio of -0.18 and a beta of 0.16. The company’s 50-day moving average price is $0.62 and its 200 day moving average price is $0.63.

Hedge Funds Weigh In On Lifeward

A number of hedge funds have recently modified their holdings of LFWD. HRT Financial LP raised its holdings in Lifeward by 149.7% in the 4th quarter. HRT Financial LP now owns 49,081 shares of the company’s stock valued at $28,000 after buying an additional 29,423 shares during the period. Jane Street Group LLC increased its position in shares of Lifeward by 77.3% during the fourth quarter. Jane Street Group LLC now owns 68,631 shares of the company’s stock valued at $40,000 after acquiring an additional 29,927 shares during the last quarter. Finally, Citadel Advisors LLC raised its stake in shares of Lifeward by 1,271.8% in the 3rd quarter. Citadel Advisors LLC now owns 214,006 shares of the company’s stock valued at $152,000 after acquiring an additional 198,406 shares during the period. 26.76% of the stock is currently owned by hedge funds and other institutional investors.

Lifeward Company Profile

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.